Frank J. Loughery, Abbott Laboratories divisional vice president, wrote in a comment letter to the Financial Accounting Standards Board that there should be a reconsideration of the exit price concept in FASBs proposal on fair-value measurement. A story in the Oct. 9 P&I Daily could have given the impression that Abbott had broader concerns about fair value.
Clarification
Sponsored
White Papers
Sponsored Content
Partner Content